CasNo.7082-71-5,ISONICOTINIC ANHYDRIDE,,(7082-71-5) Suppliers

1 Kilogram	Negotiable

Min.Order :1 Kilogram
Purity: ≥ 99.0%
Payment Terms : L/C,D/A,D/P,T/T,,MoneyGram,Other

Keywords

7082-71-5 Isonicotinic anhydride reMainder picolinic and nicotinic acid-anhydride

Quick Details

Appearance:White Powder
Application:API
PackAge:NW 1kg/foil bag; 20-25kg/drum or carton
ProductionCapacity:20|Metric Ton|Month
Storage:Stored in a dark, cool, ventilated and dry place
Transportation:by air/sea/express, according to request.

Superiority:

Product Name:   ISONICOTINIC ANHYDRIDE
Synonyms:   Isonicotinic anhydride, 90%, remainder picolinic and nicotinic acid-anhydride;Isonicotinic anhydride, remainder picolinic and nicotinic acid-anhydride;Bis(4-pyridinecarboxylic)anhydride;PYRIDINE-4-CARBOXYLIC ACID ANHYDRIDE;IsonicotinicAnhydride90%;Isonicotinic anhydride, HPLC 90%;4-PYRIDINECARBOXYLIC ACID ANHYDRIDE;ISONICOTINIC ANHYDRIDE
CAS:   7082-71-5
MF:   C12H8N2O3
MW:   228.2
EINECS:   230-382-6
Product Categories:   Building Blocks;C12;Heterocyclic Compounds;C9 to C46;Chemical Synthesis;Heterocyclic Building Blocks;Heterocyclic Building Blocks;Pyridines
Mol File:   7082-71-5.mol

Details:

Wuhan BJM Pharm Inc. was found in 2013, located in Hubei Province, where has long history, rich culture, convenient traffic, beautiful environment and preferential policy.

We have two factories in Dezhou , Shandong and Xianning, Hubei. The factory covers an area of 48,000 square meters with the building area of 26,000 square meters. We are specialized in the manufacture of pharmaceutical intermediates and cosmetic additives with good inspection equipments and innovative R & D capability.

In 2006, We established Lingxian Microworld Chemical New Material Co,.Ltd.

In 2008, We passed ISO quality system certificate

In 2013, We established Wuhan Benjamin Pharmaceutical Chemical Co.,Ltd , and obtain self-operation Import & Export right, mainly responsible for domestic and foreign business. At the same time, we set up R&D lab in Wuhan,Hubei province, can undertake various custom synthesis of intermediates and APIs.

In 2016, obtain a registered trademark “ BJM ”.

In 2017, we applied for the invention patent of TRIS, and in 2018, we applied for the invention patent of ERDOSTAN intermediate（DL-HOMO）. At present, we have6 patents passed the preliminary examination, and 4 patents are under examination and approval.

In 2019, we purchased a R&D and office building with a total area of 2500 square meters, as our headquarters in Wuhan.

In 2020, we registered BJM Pharm Yunmeng Co., Ltd, and the new production base settled in Geputan chemical park with a total area of 50000 square meters.

We stick to the principle as: people-oriented, customer first, Hope to establish a win-win business relationship with all friends.